Clinical Chemistry
Specimens
2 human-based urine samples, 5 mL
Examinations
Alpha-PVP, Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cannabinoids, Carbamazepine, Cocaine +metabolites, Codeine, Dextropropoxyphene, EDDP, Fencyclidine, Fentanyl, Gamma-hydroxybutyrate (GHB), Ketamine, LSD, MDMA, MDPV, Metamphetamine, Methaqualone, Methadone +metabolites, Methylphenidate, Morphine, Opiates Oxycodone, Paracetamol, Pregabalin, Salicylate, Tricyclic- antidepr. Tramadol
Important Notes
For clinical laboratories and POCT sites. Expert laboratory confirmatory results are provided. Results are reported as positive or negative. 3 results processed
Microbiology
Specimens
3 plasma samples, 0.5 mL.
Examinations
MonAb
Important Notes
For clinical laboratories and POCT sites.
Microbiology
Specimens
3 plasma samples, 1.4 mL
Examinations
EBNA AbG, EBV VCA AbG, EBV VCA AbM, IgG Avidity and post-analytical clinical interpretation
Important Notes
Others
Specimens
3 digital ECG registrations (images).
Examinations
Technical quality and findings.
Important Notes
The scheme is designed for nurses and general practitioners as well as for personnel in POCT units. Participants are evaluated on their responses on technical quality, findings or both if given.
Others
Specimens
An ELISA-plate with built-in gray glass filters.
Examinations
Control for the absorbance scale in ELISA reader.
Important Notes
1 round per year.
Absorbance traceable to NIST Control of the absorbance scale of ELISA readers. Organised in co-operation with DEKS. Register orders before the end of December.
Clinical Chemistry
Specimens
3 test tubes containing synthetic latex solution, 3 mL.
Examinations
ESR.
Important Notes
Only for Alifax analysers.
Clinical Chemistry
Specimens
3 test tubes containing synthetic latex solution, 3 mL.
Examinations
ESR.
Important Notes
Only for Alifax analysers.
Multiplex
Specimens
3 samples. Either lyophilised mixtures of bacteria and/or simulated samples, 1 mL.
Examinations
Direct nucleic acid detection. Pathogens included are Aeromonas, Campylobacter, C difficile, E. coli EHEC (stx1/stx2), E. coli EAEC, E. coli EIEC, E. coli EPEC, E. coli ETEC, Plesiomonas, Salmonella, Shigella and Yersinia.
Important Notes
During the period of one calendar year, a comprehensive selection of listed pathogens will be covered.
Clinical Chemistry
Specimens
2 lyophilised faecal specimens, 0.5 mL.
Examinations
Calprotectin.
Important Notes
Microbiology
Specimens
2 lyophilised mixtures of bacteria.
Examinations
Culture, identification and antimicrobial susceptibility (rounds 2 and 4). In addition to culture, samples are also suitable for direct nucleic acid detection. Pathogens included are Aeromonas, Campylobacter, Plesiomonas, Salmonella, Shigella and Yersinia.
Important Notes
Clinical Chemistry
Specimens
2 preparations that include human haemoglobin, 0.5 mL.
Examinations
Qualitative detection of Hb in human faeces.
Important Notes
For clinical laboratories and POCT sites.